ZP
CYTK icon

Zimmer Partners’s Cytokinetics CYTK Stock Holding History

Zimmer Partners’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,000
Closed -$2.75M – 135
2025
Q3 		$2.75M Sell
50,000
-26,500
-35% -$1.09M 0.07% 119
2025
Q2 		$2.53M Sell
76,500
-5,632
-7% -$196K 0.06% 130
2025
Q1 		$3.3M Buy
82,132
+44,132
+116% +$2.03M 0.07% 137
2024
Q4 		$1.79M Sell
38,000
-39,200
-51% -$2.04M 0.03% 133
2024
Q3 		$4.08M Sell
77,200
-15,000
-16% -$836K 0.08% 112
2024
Q2 		$5M Buy
92,200
+53,600
+139% +$3.24M 0.1% 109
2024
Q1 		$2.71M Buy
+38,600
New +$2.99M 0.06% 107
2023
Q3 		– Sell
-50,000
Closed -$1.63M – 131
2023
Q2 		$1.63M Buy
+50,000
New +$1.85M 0.04% 97

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return